Direct-Acting Oral Anticoagulants
Tracking # 20-639345
Course overview
Pharmacists/NP 1.Educate patients with non-valvular AF about stroke prevention. Discuss the signs of a DVT and its treatment. 2.Discuss the advantages and disadvantages of DOACs compared with warfarin. Recognize the FDA-approved indications for different DOACs. 3.List DOAC side effects, dosing regimens, and drug interactions. Discuss their use in patients with kidney impairment. 4.Discuss bleeding management and the use of DOAC reversal agents. Counsel patients about the signs of bleeding linked to anticoagulation. Pharmacy Technicians 1.List the generic and brand names for the five Direct-acting Oral Anticoagulants (DOACs) currently on the market. Identify 1 administration factor to consider with each medication. 2.State 2 advantages DOACs have over warfarin. Identify common side effects of anticoagulants. 3.For each DOAC, list FDA approved indications; discuss the appropriate dosing for each indication. 4.List the DOAC reversal agents currently on the market. Recognize when the use of a reversal agent is indicated and when it is contraindicated.
Subject areas
This course counts toward the state boards and subject areas below.